Cenicriviroc: Completed Phase IIb enrollment

Tobira completed enrollment of >252 patients in the double-blind, placebo-controlled, international Phase IIb CENTAUR trial evaluating 150 mg oral cenicriviroc in adults with NASH and liver fibrosis. ...